Latest Advocacy Group Content

Latest Content

Hope And The Patient With Cancer

October 18th 2020, 8:00pm

By Richard E. Farmer


Hope is a potent ally for the patient with cancer, and it is a response that helps inform a patient's journey with cancer.

When An Oncology Nurse Is Your Parental Guide

October 18th 2020, 1:00pm


On the cancer journey, oncology nurses are more than just a helping hand. They can be your second "mom" and guide you through the confusing parts.

A Week of Radiation Therapy Following Early-Stage Breast Cancer Surgery Appears as Safe and Effective as Longer Courses

October 17th 2020, 8:00pm

By Beth Fand Incollingo


Just one week of radiation therapy after surgery for early-stage breast cancer is as safe and effective as longer courses, researchers report.

Living As A 'Triple Threat' Breast Cancer Survivor

October 17th 2020, 6:00pm


Understanding cancer as a professional is one thing, but once you go through the journey it takes on a whole different understanding.

CURE®’s Annual Ovarian Cancer Heroes Program Goes Virtual Amid COVID-19 to Honor Three Women Who Have Dedicated Their Lives to Patients with Gynecologic Cancer

October 17th 2020, 1:00pm

By Conor Killmurray


An oncology nurse, patient turned advocate and cancer biologist were honored during CURE®’s third annual Ovarian Cancer Heroes program where they got to share messages of resiliency with a virtual audience.

FDA Grants Regular Approval to Venclexta Combo for Untreated Acute Myeloid Leukemia

October 16th 2020, 6:20pm

By Kristie L. Kahl


After granting accelerated approval in 2018, the Food and Drug Administration approved Venclexta in combination with Vidaza, Dacogen or low dose cytarabine in newly diagnosed patients with AML.

Aliqopa in Combination with Rituxan Meets Primary End Point for Indolent Non-Hodgkin’s Lymphoma

October 16th 2020, 6:00pm

By Jessica Skarzynski


A study evaluating the efficacy of Aliqopa (copanlisib) in combination with Rituxan (rituximab) in patients with indolent non-Hodgkin’s lymphoma who have relapsed after at least one prior line of therapy also involving Rituxan has met its primary endpoint, according to Aliqopa’s manufacturer, Bayer.

Becoming The Supporter Over The Cancer Survivor

October 16th 2020, 4:00pm

By Danielle Ripley-Burgess


When my friend was diagnosed with breast cancer, my role became supporter over survivor.

Friday Frontline: A Father Receiving Treatment for Leukemia Surprises His Daughter on Her Wedding Day; ‘The Wanted’ Singer Tom Parker Diagnosed with Inoperable Brain Tumor; and More

October 16th 2020, 3:00pm

By Ryan McDonald


From “The Wanted” singer Tom Parker announcing he has been diagnosed with stage 4 glioblastoma and is undergoing treatment, to a Houston-area father receiving treatment for leukemia surprising his daughter on her wedding day, here’s what’s happening in the cancer landscape this week.

CURE®’s Inaugural Lung Cancer Heroes Program Honors Several Individuals Who Have Dedicated Their Lives and Careers to Improving Care for Patients

October 16th 2020, 1:00pm

By Ryan McDonald


Two physicians, a nurse and a patient advocate were honored during CURE®’s first ever Lung Cancer Heroes program.